The Effect of Sulodexide on the Incidence of Cardiovascular Outcomes in Patients With Vascular Disorders
Philippine Journal of Cardiology · 2025
DOI: 10.69944/pjc.06659058d5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philippine Journal of Cardiology, 2025. Verfasst von Eugenio B Reyes und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives: Among patients with macrovascular and microvascular disease, we investigated the association between sulodexide and cardiovascular (CV) outcomes and adverse events.
Methods
We conducted a meta-analysis of randomized control trials (RCTs) reporting CV outcomes and adverse events in patients with vascular disease receiving sulodexide for any indication versus control. The following outcomes were investigated: any CV event, myocardial infarction, CV death, bleeding events and gastrointestinal symptoms.
Results
Twelve studies with a total of 8,436 patients were included. Sulodexide resulted in a significant reduction in CV events (OR 0.51 [95% confidence interval 0.41-0.73]; p
Zitieren
APA
Reyes, E. B., Cheng-Bromeo, P. V. C. Y., & Santos, N. J. C. (2025). The Effect of Sulodexide on the Incidence of Cardiovascular Outcomes in Patients With Vascular Disorders. Philippine Journal of Cardiology. https://doi.org/10.69944/pjc.06659058d5
Vancouver
Reyes EB, Cheng-Bromeo PVCY, Santos NJC. The Effect of Sulodexide on the Incidence of Cardiovascular Outcomes in Patients With Vascular Disorders. Philippine Journal of Cardiology. 2025. doi:10.69944/pjc.06659058d5
BibTeX
@article{Reyes2025,
author = {Reyes, Eugenio B and Cheng-Bromeo, Paula Victoria Catherine Y and Santos, Nigel Jeronimo C},
title = {The Effect of Sulodexide on the Incidence of Cardiovascular Outcomes in Patients With Vascular Disorders},
journal = {Philippine Journal of Cardiology},
year = {2025},
doi = {10.69944/pjc.06659058d5}
}
EUVIMED